
- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period: 2024-2030
One of the main issues with transradial coronary intervention is radial artery spasm (TRI). When an artery is spasming, a sheath introducer with a hydrophilic covering may lessen the likelihood of spasm and ease removal from the radial artery.
Following an in vitro comparison of the friction resistance of sheath introducers with and without hydrophilic coating (each with nine samples), 37 and 36 patients, respectively, undergoing elective TRI with a 6 Fr introducer sheath, were randomly assigned to receive one of the two types of sheath introducers.
In an in vitro model, a hydrophilic coating on the sheath introducer reduced friction resistance by 70% (P 0.00001) and made it easier to remove the sheath after TRI was complete. Sheath introducers with hydrophilic coatings are helpful for TRI.
The Global Hydrophilic Coated Introducer Sheath market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
The outside diameter of the Glidesheath Slender Sheath is lowered by one French size while maintaining the equal interior diameter due to its thin wall structure With Terumo's exclusive Glide Technology hydrophilic covering, the Glidesheath Slender Sheath enables easy insertion and removal.
Smaller diameter sheaths with a tapered tip and dedicated radial sheaths with hydrophilic coating may lower the risk of arterial spasm and radial occlusion. The Glidesheath Slender Sheath, which uses Terumo's Glide Technology, is the only thin wall radial sheath on the market to exhibit exceptional and reliable performance in lubricity and lubricity durability over time.
The Glidesheath Slender Sheath's thin wall technology is intended to promote nontraumatic radial access while preserving an ideal sheath-to-artery ratio. Permits medical professionals to undertake interventional and diagnostic treatments without upgrading to a larger sheath.
Recent advances in the development of hydrophilic coated introducer sheath sheaths include the development of hydrophilic coatings that aim to reduce frictional resistances during sheath placement and removal. Although hydrophilic-coated sheaths have been reported to result in a reduction in the occurrences of discomfort and clinical spasm, Many instances has addressed the questions of whether sheath coating results in less endothelial dysfunction.
The development of hydrophilic coating purportedly leads to reduction in the force required to remove the sheath and the likelihood of damage during removal. There is some evidence that sheath coating has beneficial clinical effects, including reduced spasm and pain.Therefore hypothesized that sheath coating would limit impacts on vessel function and that diminished impact on the endothelium may preserve its well-established antiatherogenic properties
The Slender Sheath is the only thin wall radial sheath on the market with superior and consistent performance in lubricity and lubricity durability over time. It features Terumo's Glide Technology.The Slender Sheath is the only thin wall sheath that performs best in class in all of the critical features that have been identified by the American Heart Association as contributing to decreased spasm.
The Slender Sheath's thin wall technology allows for atraumatic radial access while maintaining an optimal sheath-to-artery ratio. This enables doctors to perform diagnostic and interventional procedures without having to upgrade to a larger sheath.
The hydrophilic coated Sheath was identified as the most recognized, most influential, most utilized and most trusted radial access sheath in the market.The Introducer Sheath comes in three kit options.The Slender Stainless Steel Kit is intended for anterior wall puncture and is available in 5F, 6F and 7F sizes with length options of 10cm and 16cm. Each kit comes with a stainless steel guidewire and needle.
The Medtronic Sentrant Introducer Sheaths with Hydrophilic Coating are intended to provide a conduit for the insertion of diagnostic or endovascular devices into the vasculature and to minimise blood loss associated with such insertions.
Sl no | Topic |
1 | Market Segmentation |
2 | Scope of the report |
3 | Abbreviations |
4 | Research Methodology |
5 | Executive Summary |
6 | Introduction |
7 | Insights from Industry stakeholders |
8 | Cost breakdown of Product by sub-components and average profit margin |
9 | Disruptive innovation in the Industry |
10 | Technology trends in the Industry |
11 | Consumer trends in the industry |
12 | Recent Production Milestones |
13 | Component Manufacturing in US, EU and China |
14 | COVID-19 impact on overall market |
15 | COVID-19 impact on Production of components |
16 | COVID-19 impact on Point of sale |
17 | Market Segmentation, Dynamics and Forecast by Geography, 2024-2030 |
18 | Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030 |
19 | Market Segmentation, Dynamics and Forecast by Application, 2024-2030 |
20 | Market Segmentation, Dynamics and Forecast by End use, 2024-2030 |
21 | Product installation rate by OEM, 2023 |
22 | Incline/Decline in Average B-2-B selling price in past 5 years |
23 | Competition from substitute products |
24 | Gross margin and average profitability of suppliers |
25 | New product development in past 12 months |
26 | M&A in past 12 months |
27 | Growth strategy of leading players |
28 | Market share of vendors, 2023 |
29 | Company Profiles |
30 | Unmet needs and opportunity for new suppliers |
31 | Conclusion |
32 | Appendix |